Literature DB >> 18992754

Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes.

Shigemiki Omiya1, Shungo Hikoso, Yukiko Imanishi, Atsuhiro Saito, Osamu Yamaguchi, Toshihiro Takeda, Isamu Mizote, Takafumi Oka, Manabu Taneike, Yuko Nakano, Yasushi Matsumura, Kazuhiko Nishida, Yoshiki Sawa, Masatsugu Hori, Kinya Otsu.   

Abstract

Ferritin heavy chain (FHC) protein was significantly reduced in murine failing hearts following left coronary ligation or thoracic transverse aortic constriction. The mRNA expression of FHC was not significantly altered in failing hearts, compared to that in control sham-operated hearts. Prussian blue staining revealed spotty iron depositions in myocardial infarct failing hearts. Oxidative stress was enhanced in the myocardial infarct failing hearts, as evidenced by increases in 4-hydroxy-2-nonenal and 8-hydroxy-2'-deoxyguanosine immunoreactivity. To clarify the functional significance of FHC downregulation in hearts, we infected rat neonatal cardiomyocytes with adenoviral vector expressing short hairpin RNA targeted to FHC (Ad-FHC-RNAi). The downregulation of FHC induced a reduction in the viability of cardiomyocytes. The relative number of iron deposition-, 4-hydroxy-2-nonenal- or 8-hydroxy-2'-deoxyguanosine-positive cardiomyocytes was significantly higher in Ad-FHC-RNAi-infected cardiomyocytes than in control vector-infected cardiomyocytes. Treatment of Ad-FHC-RNAi-infected cardiomyocytes with desferrioxamine, an iron chelator, significantly reduced the number of iron, 4-hydroxy-2-nonenal or 8-hydroxy-2'-deoxyguanosine-positive cells, and increased viability. In addition, treatment with N-acetyl cysteine, an antioxidant, significantly reduced the number of 4-hydroxy-2-nonenal- or 8-hydroxy-2'-deoxyguanosine-positive cells. Reduced viability in Ad-FHC-RNAi-infected cardiomyocytes was significantly improved with N-acetyl cysteine treatment. These findings indicate that excessive free iron and the resultant enhanced oxidative stress caused by downregulation of FHC lead to cardiomyocyte death. The decrease in FHC expression in failing hearts may play an important role in the pathogenesis of heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992754     DOI: 10.1016/j.yjmcc.2008.09.714

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

1.  Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.

Authors:  Yuichi Baba; Jason K Higa; Briana K Shimada; Kate M Horiuchi; Tomohiro Suhara; Motoi Kobayashi; Jonathan D Woo; Hiroko Aoyagi; Karra S Marh; Hiroaki Kitaoka; Takashi Matsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-10       Impact factor: 4.733

2.  Mössbauer Spectra of Mouse Hearts Reveal Age-dependent Changes in Mitochondrial and Ferritin Iron Levels.

Authors:  Joshua D Wofford; Mrinmoy Chakrabarti; Paul A Lindahl
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

3.  Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease.

Authors:  Zhen-Hua Shi; Guangjun Nie; Xiang-Lin Duan; Tracey Rouault; Wen-Shuang Wu; Bo Ning; Nan Zhang; Yan-Zhong Chang; Bao-Lu Zhao
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

4.  Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.

Authors:  Anindita Das; David Durrant; Saisudha Koka; Fadi N Salloum; Lei Xi; Rakesh C Kukreja
Journal:  J Biol Chem       Date:  2013-12-26       Impact factor: 5.157

5.  Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation.

Authors:  Shigemiki Omiya; Yosuke Omori; Manabu Taneike; Andrea Protti; Osamu Yamaguchi; Shizuo Akira; Ajay M Shah; Kazuhiko Nishida; Kinya Otsu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-21       Impact factor: 4.733

6.  Mansouramycin C kills cancer cells through reactive oxygen species production mediated by opening of mitochondrial permeability transition pore.

Authors:  Shan Kuang; Ge Liu; Ruobing Cao; Linlin Zhang; Qiang Yu; Chaomin Sun
Journal:  Oncotarget       Date:  2017-10-24

7.  Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.

Authors:  I Aversa; F Zolea; C Ieranò; S Bulotta; A M Trotta; M C Faniello; C De Marco; D Malanga; F Biamonte; G Viglietto; G Cuda; S Scala; F Costanzo
Journal:  J Exp Clin Cancer Res       Date:  2017-08-03

8.  Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.

Authors:  Scott M Filippone; Arun Samidurai; Sean K Roh; Chad K Cain; Jun He; Fadi N Salloum; Rakesh C Kukreja; Anindita Das
Journal:  Oxid Med Cell Longev       Date:  2017-03-08       Impact factor: 6.543

9.  Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation.

Authors:  Tengfei Huang; Yanjie Sun; Yongli Li; Tingting Wang; Yun Fu; Cuiping Li; Changzheng Li
Journal:  Oxid Med Cell Longev       Date:  2018-08-05       Impact factor: 6.543

Review 10.  The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.

Authors:  Tanya Ravingerová; Lucia Kindernay; Monika Barteková; Miroslav Ferko; Adriana Adameová; Vladislava Zohdi; Iveta Bernátová; Kristina Ferenczyová; Antigone Lazou
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.